Cantargia publishes half year report
Cantargia AB’s half year report for the period January until June 2018 is now available on the company’s web page www.cantargia.com/en/investors/financial-reports.Significant events in the second quarter Preclinical · In April, Cantargia presented new data on the blocking of metastases using antibodies against IL1RAP at the AACR annual meeting in Chicago, USA. · During the period, new data was released showing that CAN04 has potential for treatment of more cancer diseases than has previously been communicated. · New data was reported showing that CAN04 has positive effects in